Brighton Jones’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Brighton Jones's WST Position: Q3 2026 in Review
Brighton Jones reduced its West Pharmaceutical (WST) stake by 1.2% in Q3 2026, selling an estimated $2.47K and leaving 587 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1225.
Brighton Jones first reported a position in WST in Q3 2025 and has held it in 3 quarters since. The position peaked at $660K in Q3 2025. 751 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Brighton Jones held 587 shares of West Pharmaceutical worth $218K as of Q3 2026.
- Brighton Jones sold 7 West Pharmaceutical shares in Q3 2026, an estimated $2.47K.
- West Pharmaceutical made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1225 holding.
- Brighton Jones first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
- Brighton Jones's West Pharmaceutical position peaked at $660K in Q3 2025.
- 751 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.